Macular edema constitutes a serious pathologic entity of ophthalmology resulting in vision
loss with a remarkable impact on the quality of life of patients. It is the final common pathway …

Uveitis (intraocular inflammation) is a potentially blinding group of, probably autoimmune,
conditions predominantly occurring in the working age group. Although the aetiology is …

“When the IOP rises in uveitic patients, nearly all require treatment with anti-inflammatory
and antiglaucoma medications.” side-effect profile, whereas alkylating agents are …

The management of noninfectious uveitis is constantly evolving. A new “biologic era” in
treatment began after the effectiveness of tumor necrosis factor-alpha blocking drugs was …

The Ocular Inflammatory Disease and Uveitis Manual is a practical, concise clinical
reference for resident and practicing ophthalmologists and optometrists treating uveitis …

Treatment of inflammatory diseases of the eye is especially challenging. Although
physicians in antiquity had recognized the existence of ocular inflammatory disease, their …

Over the past 2 decades therapy for the treatment of intraocular inflammation (uveitis) has
developed into a highly differentiated approach with an increasing number of drug options …

Systemic drug-induced ocular side effects are increasing because of the vast numbers of
new drugs being introduced. Reports of drug-induced ocular toxicity must be well …

Inflammatory diseases of the eye were known to the ancients, but only recently have the
underlying mechanisms to this problem become better defined. During the middle portion of …

Written by international authorities in ocular toxicology, including the Founder of The
National Registry of Drug-Induced Side Effects and its current Director, this essential …